AtriCure
Generated by Meeveem AI
"Global leader in surgical devices for atrial fibrillation treatment and pain management"
Mason, OH
•1000+ Employees
•Medical Devices
About AtriCure
AtriCure develops surgical devices that treat atrial fibrillation and manage post-operative pain. The company's cardiac ablation systems and atrial appendage exclusion devices help surgeons address Afib in patients undergoing heart surgery, offering solutions backed by FDA approval and clinical trials. Over 700,000 patients worldwide have been treated with AtriCure ablation technologies. The company serves cardiothoracic surgeons, electrophysiologists, and thoracic surgeons across 50 countries. Its portfolio includes the Isolator Synergy Ablation System for persistent Afib, the AtriClip device for appendage management, and cryoICE technology for non-opioid pain relief, helping reduce cardiac arrhythmias and improve patient outcomes.
1400
Team Members
2000
Founded
Medical Devices
Sector
Hybrid
Work Environment
Our Vision
A world where atrial fibrillation and surgical pain no longer limit patient health, where advanced cardiac devices enable complete treatment, and where people facing heart rhythm disorders receive surgical care that transforms outcomes.
Our Mission
We are passionately focused on healing the lives of those affected by Afib and pain after surgery.